SCHEMBL30179264

SCHEMBL30179264

COC(=O)C1CC(C#N)(c2cccc(F)c2)CCC1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 1/20 0.44
PSEN2 P49810 1/20 0.44
APH1B Q8WW43 1/20 0.44
NCSTN Q92542 1/20 0.44
APH1A Q96BI3 1/20 0.44
PSENEN Q9NZ42 1/20 0.44
CCR2 P41597 1/20 0.40
ADRA1D P25100 3/20 0.39
ADRA1A P35348 3/20 0.39
ADRA1B P35368 3/20 0.39
RORC P51449 1/20 0.39
BDKRB1 P46663 1/20 0.37
ALDH1A1 P00352 1/20 0.36
KMT2A Q03164 1/20 0.35
PDE4A P27815 3/20 0.35
PDE4B Q07343 3/20 0.35
PDE4C Q08493 3/20 0.35
PDE4D Q08499 3/20 0.35
GAA P10253 1/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1557184 1.00 PSEN1 (0.44) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL22423723 0.89 PSEN1 (0.44) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL4429927 0.88 CCR2 (0.39) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL4432445 0.87 PSEN1 (0.42) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL11076769 0.87 KMT2A (0.50) ALDH1A1KMT2APDE4APDE4BPDE4C
SCHEMBL1558214 0.86 RORC (0.45) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL735539 0.86 MEN1 (0.42) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL3516451 0.83 OPRM1 (0.46) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL3522150 0.81 SLC6A4 (0.54) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL11091127 0.81 PDE4B (0.54) KMT2APDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109996792-B Heterocyclic compounds having activity as modulators of muscarinic M1 and/or M4 receptors in the treatment of CNS diseases and pain 赫普泰雅治疗有限公司 2023-02-17 CN disclosed